Skip to main content
. 2022 Feb 8;31(5):784–805. doi: 10.1002/hec.4477

TABLE 3.

Prevalence and mean costs by individual characteristics: (rebalanced) sample versus population

Sample (GP data) Rebalanced sample Population
Prevalence Mean costs Prevalence Mean costs Prevalence Mean costs
Total 100% 2095 100% 2043 100% 2043
Men, 1–17 years 10.0% 939 10.0% 956 10.0% 970
Men, 19–34 years 9.8% 722 10.4% 710 10.4% 702
Men, 35–44 years 6.2% 1045 6.3% 1011 6.3% 1005
Men, 45–54 years 7.7% 1538 7.7% 1532 7.7% 1548
Men, 55–64 years 6.9% 2708 6.6% 2669 6.6% 2667
Men, 65 years or over 8.7% 5131 8.4% 5054 8.4% 5066
Women, 1–17 years 9.5% 850 9.5% 851 9.5% 849
Women, 19–34 years 9.7% 1512 10.3% 1487 10.3% 1486
Women, 35–44 years 6.5% 1536 6.5% 1562 6.5% 1566
Women, 45–54 years 7.8% 1815 7.7% 1813 7.7% 1813
Women, 55–64 years 6.9% 2565 6.7% 2553 6.7% 2550
Women, 65 years or over 10.3% 4550 10.0% 4463 10.0% 4444
No PCG 79.2% 1258 80.1% 1240 80.1% 1240
At least one PCG 20.8% 5282 19.9% 5268 19.9% 5269
No DCG 87.7% 1346 88.2% 1327 88.2% 1324
At least one DCG 12.3% 7440 11.8% 7379 11.8% 7409
No DMEG 96.4% 1853 96.6% 1813 96.6% 1811
At least one DMEG 3.6% 8642 3.4% 8518 3.4% 8576
No PDG 98.2% 2002 98.2% 1953 98.2% 1952
At least one PDG 1.8% 7117 1.8% 6915 1.8% 6984

Note: spending is presented in euros per person per year. Prevalence is calculated as a percentage of total insured years in the population and (rebalanced) sample.

Abbreviations: DCG, diagnosis‐based cost groups; DMEG, durable medical equipment groups; GP, general practitioner; PCG, pharmacy‐based cost groups.